Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
- PMID: 29287769
- PMCID: PMC5907911
- DOI: 10.1016/j.semarthrit.2017.12.003
Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Abstract
Objectives: To gather expert opinion on the conduct of clinical trials that will facilitate regulatory review and approval of appropriate efficacious pharmacological treatments for hand osteoarthritis (OA), an area of high unmet clinical need.
Methods: The European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal diseases (ESCEO) organized a working group under the auspices of the International Osteoporosis Foundation (IOF) and the World Health Organization (WHO).
Results: This consensus guideline is intended to provide a reference tool for practice, and should allow for better standardization of the conduct of clinical trials in hand OA. Hand OA is a heterogeneous disease affecting different, and often multiple, joints of the thumb and fingers. It was recognized that the various phenotypes and limitations of diagnostic criteria may make the results of hand OA trials difficult to interpret. Nonetheless, practical recommendations for the conduct of clinical trials of both symptom and structure modifying drugs are outlined in this consensus statement, including guidance on study design, execution, and analysis.
Conclusions: While the working group acknowledges that the methodology for performing clinical trials in hand OA will evolve as knowledge of the disease increases, it is hoped that this guidance will support the development of new pharmacological treatments targeting hand OA.
Keywords: Clinical trials; Guidelines; Hand osteoarthritis; Pharmacological treatment.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).Drugs Aging. 2019 Apr;36(Suppl 1):145-159. doi: 10.1007/s40266-019-00667-8. Drugs Aging. 2019. PMID: 31073927 Free PMC article.
-
Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging.Calcif Tissue Int. 2023 Feb;112(2):197-217. doi: 10.1007/s00223-022-01054-z. Epub 2023 Jan 12. Calcif Tissue Int. 2023. PMID: 36633611 Free PMC article. Review.
-
A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).Semin Arthritis Rheum. 2014 Dec;44(3):271-82. doi: 10.1016/j.semarthrit.2014.06.005. Epub 2014 Jun 27. Semin Arthritis Rheum. 2014. PMID: 25086470
-
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).Semin Arthritis Rheum. 2019 Dec;49(3):337-350. doi: 10.1016/j.semarthrit.2019.04.008. Epub 2019 Apr 30. Semin Arthritis Rheum. 2019. PMID: 31126594 Review.
-
OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis.Osteoarthritis Cartilage. 2015 May;23(5):772-86. doi: 10.1016/j.joca.2015.03.007. Osteoarthritis Cartilage. 2015. PMID: 25952348 Review.
Cited by
-
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis.Sci Rep. 2024 May 23;14(1):11792. doi: 10.1038/s41598-024-62428-x. Sci Rep. 2024. PMID: 38783008 Free PMC article. Clinical Trial.
-
The woman's hand.Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S108. doi: 10.1590/1806-9282.2023S108. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37556627 Free PMC article. No abstract available.
-
Mapping knowledge landscapes and emerging trends of the links between osteoarthritis and osteoporosis: A bibliometric analysis.Front Public Health. 2022 Dec 19;10:1019691. doi: 10.3389/fpubh.2022.1019691. eCollection 2022. Front Public Health. 2022. PMID: 36600941 Free PMC article.
-
Ageing and Osteoarthritis Synergically Affect Human Synoviocyte Cells: An In Vitro Study on Sex Differences.J Clin Med. 2022 Nov 30;11(23):7125. doi: 10.3390/jcm11237125. J Clin Med. 2022. PMID: 36498698 Free PMC article.
-
Prescription-grade crystalline glucosamine sulfate as an add-on therapy to conventional treatments in erosive osteoarthritis of the hand: results from a 6-month observational retrospective study.Aging Clin Exp Res. 2022 Jul;34(7):1613-1625. doi: 10.1007/s40520-022-02151-7. Epub 2022 May 30. Aging Clin Exp Res. 2022. PMID: 35637324 Free PMC article.
References
-
- Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage. 2011;19:1270–85. - PubMed
-
- Kloppenburg M, Kwok WY. Hand osteoarthritis--a heterogeneous disorder. Nat Rev Rheumatol. 2011;8:22–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 19583/ARC_/Arthritis Research UK/United Kingdom
- MC_U147574237/MRC_/Medical Research Council/United Kingdom
- MC_U147574234/MRC_/Medical Research Council/United Kingdom
- MC_U147585819/MRC_/Medical Research Council/United Kingdom
- MC_UP_A620_1014/MRC_/Medical Research Council/United Kingdom
- 19583/VAC_/Versus Arthritis/United Kingdom
- MC_UU_12011/1/MRC_/Medical Research Council/United Kingdom
- G0400491/MRC_/Medical Research Council/United Kingdom
- MC_U147585824/MRC_/Medical Research Council/United Kingdom
- MC_U147585827/MRC_/Medical Research Council/United Kingdom
- MC_U147574212/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical